References
- JALangendijk, AFerlito, RPTakes, JPRodrigo, CSuárez, PStrojan, et al. Postoperative strategies after primary surgery for squamous cell carcinoma of the head and neck. Oral Oncol 2010;46:577–85.
- RWHinerman, CGMorris, RJAmdur, CDLansford, JWWerning, DBVillaret, et al. Surgery and postoperative radiotherapy for squamous cell carcinoma of the larynx and pharynx. Am J Clin Oncol 2006;29:613–21.
- PYChu, LWWang, SYChang. Surgical treatment of squamous cell carcinoma of the hypopharynx: analysis of treatment results, failure patterns, and prognostic factors. J Laryngol Otol 2004;118:443
- JBernier, JSCooper, TFPajak, Mvan Glabbeke, JBourhis, AForastiere, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005;27:843–50.
- NDenaro, EGRussi, VAdamo, IColantonio, MCMerlano. Postoperative therapy in head and neck cancer: state of the art, risk subset, prognosis and unsolved questions. Oncology 2011;81:21–9.
- JSCooper, TFPajak, AAForastiere, JJacobs, BHCampbell, SBSaxman, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937–44.
- JBernier, CDomenge, MOzsahin, KMatuszewska, JLLefebvre, RHGreiner, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945–52.
- ASGarden, JHarris, ATrotti, CUJones, LCarrascosa, JDCheng, et al. Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys 2008;71:1351–5.
- JHLee, JHSong, SNLee, JHKang, MSKim, DISun, et al. Adjuvant postoperative radiotherapy with or without chemotherapy for locally advanced squamous cell carcinoma of the head and neck: the importance of patient selection for the postoperative chemoradiotherapy. Cancer Res Treat 2013;45:31–9.
- R Development Core Team. 2012. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
- YGoto, TKodaira, KFurutani, HTachibana, NTomita, JIto, et al. Clinical outcome and patterns of recurrence of head and neck squamous cell carcinoma with a limited field of postoperative radiotherapy. Jpn J Clin Oncol 2013;43:719–25.
- BBussels, AMaes, RHermans, SNuyts, CWeltens, WVan den Bogaert. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol 2004;72:119–27.
- FDuprez, KBonte, WDe Neve, TBoterberg, WDe Gersem, IMadani. Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2011;79:450–8.
- AMChen, DGFarwell, QLuu, LMChen, SVijayakumar, JAPurdy. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2011;80:1423–9.
- DMCannon, NYLee. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008;70:660
- JABonner, PMHarari, JGiralt, RBCohen, CUJones, RKSur, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010;11:21–8.